Scientific article

Faut-il doser le BNP chez les patients avec BPCO

Published inRevue médicale suisse, vol. 8, no. 358, p. 1961-1965
Publication date2012

The dosage of natriuretic peptides improves diagnostic performance in patients with acute dyspnea when combined with clinical elements. The high sensitivity of this test allows reasonably excluding heart failure when the value is normal. Nevertheless, an increased level of this biomarker is not specific of heart failure and can be observed in different pathologies such as renal failure, sepsis or elevated pulmonary arterial pressure. We therefore analyse the diagnostic performance of natriuretic peptide in COPD patients and discuss its use for the detection of heart failure in this population.

  • Biological Markers/blood
  • Dyspnea/complications
  • Heart Failure/diagnosis
  • Humans
  • Natriuretic Peptide, Brain/blood
  • Pulmonary Disease, Chronic Obstructive/blood
Citation (ISO format)
GARIANI, Karim, PERRIER, Arnaud, MARTI, Christophe. Faut-il doser le BNP chez les patients avec BPCO. In: Revue médicale suisse, 2012, vol. 8, n° 358, p. 1961–1965.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/09/2013 5:23:00 PM
First validation12/09/2013 5:23:00 PM
Update time03/14/2023 8:42:18 PM
Status update03/14/2023 8:42:18 PM
Last indexation08/29/2023 7:30:42 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack